UNSPSC 85515130: Insertion of intraluminal device into lower artery, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of intraluminal device into lower artery, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04HY3DZ

UNSPSC 85515130 Insertion of intraluminal device into lower artery, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its clinical scope. The six recent opportunities tagged under this code span occupational medical surveillance, independent medical evaluations for disability determinations, surgical benefit carve-outs for employee health plans, pharmacy benefit management, emergency and specialty medical services for youth in custody, and temporary health professional staffing — none of which involve insertion of intraluminal devices or vascular intervention procedures. State and local governments do procure clinical services and health plan administration, but the code designation appears to reflect a mismatch between the UNSPSC taxonomy and the actual work being solicited.

The recent opportunities originate from diverse issuing bodies including state departments (Washington State Department of Transportation), county governments (Harris County, Collier County, Santa Clara County), cities (Phoenix, Long Beach), and regional health systems. Geographic activity spans Washington, Arizona, California, Florida, and Texas. Representative recent solicitations include the Washington State Department of Transportation's occupational medical surveillance RFP (due October 9, 2026), the City of Phoenix's independent medical evaluation services RFP for disability pension determinations ($750,000 over five years, due October 16, 2026), and the City of Long Beach's surgical benefit carve-out RFP for employee health plans (due October 7, 2026). Given the code's clinical specificity and the absence of relevant vascular-intervention opportunities, this code should not be pursued without verification that a specific opportunity is genuinely tagged to intraluminal device procurement.